v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance at Dec. 31, 2017 $ 152,279   $ 10 $ 435,607   $ (283,338)  
Balance (Accounting Standards Update 2016-16) at Dec. 31, 2017   $ (40)         $ (40)
Balance (Accounting Standards Update 2014-09) at Dec. 31, 2017   38,339         38,339
Balance, Shares at Dec. 31, 2017     99,157        
Vesting of early exercised stock options 239     239      
Issuance of common stock pursuant to equity incentive plans, net of taxes 25,034   $ 1 25,033      
Issuance of common stock pursuant to equity incentive plans, net of taxes, Shares     10,481        
Issuance of common stock pursuant to exercise of common stock warrants, net, Shares     141        
Stock-based compensation expense 37,674     37,674      
Share repurchases, Shares     (9)        
Unrealized gain (loss) on short-term investments (17)       $ (17)    
Net loss (8,857)         (8,857)  
Balance at Dec. 31, 2018 244,651   $ 11 498,553 (17) (253,896)  
Balance, Shares at Dec. 31, 2018     109,770        
Vesting of early exercised stock options 86     86      
Issuance of common stock pursuant to equity incentive plans, net of taxes 28,182   $ 1 28,181      
Issuance of common stock pursuant to equity incentive plans, net of taxes, Shares     6,169        
Issuance of common stock pursuant in connection with at-the-market offerings, net of issuance costs 330,539     330,539      
Issuance of common stock pursuant in connection with at-the-market offerings, net of issuance costs, Shares     3,389        
Issuance of common stock in connection with acquisition 69,684     69,684      
Issuance of common stock in connection with acquisition, Shares     571        
Stock-based compensation expense 85,175     85,175      
Share repurchases, Shares     (2)        
Unrealized gain (loss) on short-term investments 17       17    
Foreign currency translation adjustment 29       29    
Net loss (59,937)         (59,937)  
Balance at Dec. 31, 2019 698,426   $ 12 1,012,218 29 (313,833)  
Balance (Accounting Standards Update 2016-13) at Dec. 31, 2019   $ (1,066)         $ (1,066)
Balance, Shares at Dec. 31, 2019     119,897        
Vesting of early exercised stock options 38     38      
Issuance of common stock pursuant to equity incentive plans, net of taxes 16,806   $ 1 16,805      
Issuance of common stock pursuant to equity incentive plans, net of taxes, Shares     4,107        
Issuance of common stock pursuant in connection with at-the-market offerings, net of issuance costs 497,242     497,242      
Issuance of common stock pursuant in connection with at-the-market offerings, net of issuance costs, Shares     4,000        
Stock-based compensation expense 134,076     134,076      
Net loss (17,507)         (17,507)  
Balance at Dec. 31, 2020 $ 1,328,015   $ 13 $ 1,660,379 $ 29 $ (332,406)  
Balance, Shares at Dec. 31, 2020     128,004